Tampa, FL USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Moffitt Cancer Center and Community Partners to Host the 17th Annual Men’s Health Forum March 18

Moffitt Cancer Center and its community partners will once again host the annual Men’s Health Forum on Saturday, March 18, from 8 a.m.-2:30 p.m. at the University of South Florida Marshall Student Center. This marks the 17th year of the forum and...
10-Mar-2017 11:05 AM EST Add to Favorites

New Drug in Development Shows Improved Progression-Free Survival for Patients with Advanced Metastatic Midgut Neuroendocrine Tumors

A new therapy in development for the treatment of midgut neuroendocrine tumors, a rare type of cancer that occurs in the small intestine and colon, shows improved progression-free survival and response rates for patients with advanced disease....
12-Jan-2017 8:00 AM EST Add to Favorites

Moffitt Cancer Center Researchers Develop Novel Treatment to Prevent Graft-Versus-Host-Disease

TAMPA, Fla. – Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants.  In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer...
11-Jan-2017 3:05 PM EST Add to Favorites

Immune Cell Therapy Shows Promising Results for Lymphoma Patients, Says Moffitt Researchers

TAMPA, Fla. – Lymphoma is the most common blood cancer. The disease occurs when immune cells called lymphocytes multiply uncontrollably. Cancerous lymphocytes can travel throughout the body and form lymph node tumors. The body has two types of...
5-Jan-2017 12:05 PM EST Add to Favorites

Moffitt Cancer Center Researchers Report Promising Clinical Activity and Minimal Toxicities for HER2-Targeted Dendritic Cell Vaccines in Early-Stage Breast Cancer Patients

Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer...
3-Jan-2017 8:05 AM EST Add to Favorites

Moffitt Researchers Use Mathematical Modeling to Explain Evolutionary Phenomenon That Leads to Treatment Resistance

A collaborative team of researchers from Moffitt Cancer Center’s Integrated Mathematical Oncology (IMO) Program, led by Alexander Anderson, Ph.D., and Oxford University’s Department of Computer Science are using mathematical models to explain...
22-Dec-2016 8:05 AM EST Add to Favorites

Moffitt Researchers Develop First Genomics-Driven Model for Personalized Radiation Therapy

Moffitt Cancer Center researchers have their study published today in The Lancet Oncology describing a novel genomics model that allows a personalized approach to radiation therapy.
19-Dec-2016 2:05 PM EST Add to Favorites

Moffitt Cancer Center Study Shows Promising Clinical Activity, Safety Results of KTE-C19 in Aggressive B-Cell Non-Hodgkin Lymphoma

TAMPA, Fla. – Immune cellular therapy is a promising new area of cancer treatment. Anti-cancer therapeutics, such as chimeric antigen receptor (CAR) modified T cells, can be engineered to target tumor-associated antigens to attack and kill cancer...
5-Dec-2016 10:05 AM EST Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos





Chat now!